Mark R Brann - Net Worth and Insider Trading

Mark R Brann Net Worth

The estimated net worth of Mark R Brann is at least $7 Million dollars as of 2024-11-13. Mark R Brann is the President & CSO of ACADIA Pharmaceuticals Inc and owns about 370,349 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $7 Million. Details can be seen in Mark R Brann's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark R Brann has not made any transactions after 2006-06-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Mark R Brann

To

Mark R Brann Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark R Brann owns 1 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) .

Click here to see the complete history of Mark R Brann’s form 4 insider trades.

Insider Ownership Summary of Mark R Brann

Ticker Comapny Transaction Date Type of Owner
ACAD ACADIA Pharmaceuticals Inc 2006-06-16 director & President and Chief Scientific

Mark R Brann Latest Holdings Summary

Mark R Brann currently owns a total of 1 stock. Mark R Brann owns 370,349 shares of ACADIA Pharmaceuticals Inc (ACAD) as of June 16, 2006, with a value of $7 Million.

Latest Holdings of Mark R Brann

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACAD ACADIA Pharmaceuticals Inc 2006-06-16 370,349 17.94 6,644,061

Holding Weightings of Mark R Brann


Mark R Brann Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark R Brann has made a total of 0 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 20,000 shares on June 16, 2006, which brought Mark R Brann around $181,000.

Insider Trading History of Mark R Brann

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark R Brann Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark R Brann Ownership Network

Ownership Network List of Mark R Brann

No Data

Ownership Network Relation of Mark R Brann

Insider Network Chart

Mark R Brann Owned Company Details

What does ACADIA Pharmaceuticals Inc do?

Who are the key executives at ACADIA Pharmaceuticals Inc?

Mark R Brann is the director & President and Chief Scientific of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include EVP & COO & Head of Commercial Brendan Teehan , Chief Financial Officer Mark C. Schneyer , and director & PRESIDENT AND CEO Stephen Davis .

ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary

Over the past 18 months, Mark R Brann made no insider transaction in ACADIA Pharmaceuticals Inc (ACAD). Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 54,525 shares made by Mark C. Schneyer , a net sale of 319,936 shares made by Stephen Davis , and a net sale of 41,903 shares made by Brendan Teehan .

In summary, during the past 3 months, insiders sold 51,014 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 51,014 shares. During the past 18 months, 455,345 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 441,177 shares.

ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ACADIA Pharmaceuticals Inc Insider Transactions

No Available Data

Mark R Brann Mailing Address

Above is the net worth, insider trading, and ownership report for Mark R Brann. You might contact Mark R Brann via mailing address: 3911 Sorrento Valley Boulevard, San Diego Ca 92121.